Recombinant multi-species PPP1R3C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PPP1R3C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a carbohydrate binding protein that is a subunit of the protein phosphatase 1 (PP1) complex. PP1 catalyzes reversible protein phosphorylation, which is important in a wide range of cellular activities. The encoded protein affects glycogen biosynthesis by activating glycogen synthase and limiting glycogen breakdown by reducing glycogen phosphorylase activity. DNA hypermethylation of this gene has been found in colorectal cancer patients. The encoded protein also interacts with the laforin protein, which is a protein tyrosine phosphatase implicated in Lafora disease. [provided by RefSeq, Sep 2016]
The Alternative Names of target: PPP1R3C,PPP1R5,PTG,Ppp1r3c,Ppp1r5,Protein phosphatase 1 regulatory subunit 3C,Protein phosphatase 1 regulatory subunit 5 (PP1 subunit R5),Protein targeting to glycogen (PTG),R5

Target products collectionGo to PPP1R3C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9962-Ag-1/ GM-Tg-hg-IP9962-Ag-2 Human PPP1R3C protein Human
GM-Tg-rg-IP9962-Ag-1/ GM-Tg-rg-IP9962-Ag-2 Rat PPP1R3C protein Rat
GM-Tg-mg-IP9962-Ag-1/ GM-Tg-mg-IP9962-Ag-2 Mouse PPP1R3C protein Mouse
GM-Tg-cynog-IP9962-Ag-1/ GM-Tg-cynog-IP9962-Ag-2 Cynomolgus/Rhesus macaque PPP1R3C protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9962-Ag-1/ GM-Tg-felg-IP9962-Ag-2 Feline PPP1R3C protein Feline
GM-Tg-cang-IP9962-Ag-1/ GM-Tg-cang-IP9962-Ag-2 Canine PPP1R3C protein Canine
GM-Tg-bovg-IP9962-Ag-1/ GM-Tg-bovg-IP9962-Ag-2 Bovine PPP1R3C protein Bovine
GM-Tg-equg-IP9962-Ag-1/ GM-Tg-equg-IP9962-Ag-2 Equine PPP1R3C protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9962-Ag-1/ GM-Tg-hg-IP9962-Ag-2; GM-Tg-rg-IP9962-Ag-1/ GM-Tg-rg-IP9962-Ag-2;
GM-Tg-mg-IP9962-Ag-1/ GM-Tg-mg-IP9962-Ag-2; GM-Tg-cynog-IP9962-Ag-1/ GM-Tg-cynog-IP9962-Ag-2;
GM-Tg-felg-IP9962-Ag-1/ GM-Tg-felg-IP9962-Ag-2; GM-Tg-cang-IP9962-Ag-1/ GM-Tg-cang-IP9962-Ag-2;
GM-Tg-bovg-IP9962-Ag-1/ GM-Tg-bovg-IP9962-Ag-2; GM-Tg-equg-IP9962-Ag-1/ GM-Tg-equg-IP9962-Ag-2
Products Name PPP1R3C protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PPP1R3C
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PPP1R3C protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.